Data protection policy – Pharmacovigilance
Data protection policy – Pharmacovigilance SUBSTIPHARM Rules governing the processing of personal data applicable to Pharmacovigilance cases At Substipharm, we collect your personal data in order to prevent, monitor, evaluate and manage adverse health events and unusual situations (hereinafter referred to as “Pharmacovigilance“) that may be linked to our products. We need to collect and […]
Cookies policy
Cookie Policy A “cookie“ is a small information file sent to the user’s (hereinafter referred to as “User“) browser and stored on the User’s device (e.g. computer, smartphone), (hereinafter referred to as “Cookies“). This file includes information such as the User’s domain name, the User’s Internet service provider, the User’s operating system, and the date […]
Data protection policy
Data protection policy Pharmacovigilance Consult data policy Medical Information Consult data policy Quality complaint Consult data policy Business, marketing, supply, and other. Consult data policy
Term and conditions
Terms and conditions TERMS AND CONDITIONS OF USE FOR THE WEBSITE The website www.substipharm.com (hereinafter the “‘Website”‘) provides Users with information about Substipharm and contact forms and addresses so they can get in touch with Substipharm. 1. Definitions Content: means all the elements constitutingEverything that makes up the information on the Website, in particular, […]
IMOJEV Leaflet
IMOJEV Leaflet IMOJEV Leaflet You can download the IMOJEV leaflet by clicking on the link below. Download the leaflet
Press release
Press release Substipharm acquires IMOJEV® SUBSTIPHARM is proud to announce that it entered into an agreement to acquire the Japanese Encephalitis vaccine IMOJEV® from Sanofi for an undisclosed amount. IMOJEV® is indicated for the prevention of Japanese Encephalitis in both adults and children, and is currently marketed in Australia, Brunei, Cambodia, Hong Kong, Indonesia, Malaysia, […]
Complaint about the quality of one product
Product Quality Complaints France If you want to submit an inquiry regarding a Substipharm product and/or its indications: Please contact by email at qadistribution@substipharm.com Italy If you have a complaint about the quality of a Substipharm product marketed in Italy: Please contact us at the following email address: customer-italy@substipharm.com Se ha una segnalazione o un […]
Medical information
Contact medical information France If you want to submit an inquiry regarding a Substipharm product and/or its indications: contact our Medical Information on + 33 4 67 10 58 49 or at the following e-mail address: substipharm@vigipharm.fr Italy You would like to submit a request for information about a Substipharm product and/or its indications in Italy: please contact […]
ZZZ – ARCHIVE – Biologics: Vaccines version 2
Biologics: Vaccines Vaccines establishment in the Asia-Pacific region The recent acquisition in 2022 of IMOJEV® vaccine by Substipharm Biologics ® is a significant step for the company in the Pacific Asia region. This acquisition led to the purchase of a factory in Bangkok and the opening of two new subsidiaries in Singapore and Geneva, allowing […]
Pharmacovigilance
Pharmacovigilance contact France We remind you that you must contact your doctor for any medical problem. You wish to report an adverse reaction related to a Substipharm product marketed in France : You can report side effects through the national reporting system : Agence Nationale de Sécurité du Médicament et des produits de santé or […]
